The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Lee, Jaehyouk ^a   Jeong, Dong Jun ^b   Kim, Jinsun ^a   Lee, Soonduck ^a   Park, Jin Hwa ^a   Chang, Boogi ^a   Jung, Sam Il ^a   Yi, Lisha ^a   Han, Youngsoo ^a   Yang, Young ^a   Kim, Keun I ^a   Lim, Jong Seok ^a   Yang, Inchul ^c   Jeon, Seob ^d   Bae, Dong H ^d   Kim, Chang Jin ^b   Lee, Myeong Sok ^a  

^a Sookmyung Women's University   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Korea Research Institute of Standards and Science   (South Korea)

^d Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; BISULFITE; CYCLIN D1; HISTONE; KLOTHO PROTEIN; MESSENGER RNA; MYC PROTEIN; T CELL FACTOR PROTEIN; TRICHOSTATIN A; WNT PROTEIN; BETA GLUCURONIDASE;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DEACETYLATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; INVASIVE CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR;

MUS;

CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GLUCURONIDASE; HUMANS; IMMUNOBLOTTING; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; UTERINE CERVICAL NEOPLASMS; WNT PROTEINS;

EID: 77952248261     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-109     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156. 10.1002/ijc.1440, 11668491.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350. 10.1038/nrc798, 12044010.
3. Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R, Toretsky JA. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res 2005, 65:6199-6206. 10.1158/0008-5472.CAN-05-0455, 16024621.
4. Perez-Plasencia C, Duenas-Gonzalez A, Alatorre-Tavera B. Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway. Int Arch Med 2008, 1:10. 10.1186/1755-7682-1-10, 2491599, 18606007.
5. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810. 10.1146/annurev.cellbio.20.010403.113126, 15473860.
6. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008, 8:387-398. 10.1038/nrc2389, 18432252.
7. Shinohara A, Yokoyama Y, Wan X, Takahashi Y, Mori Y, Takami T, Shimokawa K, Tamaya T. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol Oncol 2001, 82:450-455. 10.1006/gyno.2001.6298, 11520139.
8. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004, 36:417-422. 10.1038/ng1330, 15034581.
9. Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 2006, 12:2109-2116. 10.1158/1078-0432.CCR-05-2468, 16609023.
10. Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, Hirata K, Itoh F, Tokino T, Mori M, Imai K, Shinomura Y. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 2007, 26:4699-4713. 10.1038/sj.onc.1210259, 17297461.
11. Suzuki H, Toyota M, Carraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, Imai K, Shinomura Y, Baylin SB, Tokino T. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 2008, 98:1147-1156. 10.1038/sj.bjc.6604259, 2275475, 18283316.
12. Duenas-Gonzalez A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 2005, 4:38. 10.1186/1476-4598-4-38, 1291396, 16248899.
13. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shirakai-Iida T, Nishikawa S, Nagai R, Nabeshima Y. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390:45-51. 10.1038/36285, 9363890.
14. Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem 2008, 389:233-241. 10.1515/BC.2008.028, 18177265.
15. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shinomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M. Suppression of aging in mice by the hormone Klotho. Science 2005, 309:1829-1833. 10.1126/science.1112766, 2536606, 16123266.
16. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ, Gutkind JS, Hwang PM, Finkel T. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007, 317:803-806. 10.1126/science.1143578, 17690294.
17. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 2008, 27:7094-7105. 10.1038/onc.2008.292, 18762812.
18. Chung MT, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Chu TY, Lai HC, Lin YW. Promoter methylation of SFRPs gene family in cervical cancer. Gynecol Oncol 2009, 112:301-306. 10.1016/j.ygyno.2008.10.004, 19038436.
19. Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 1998, 242:626-630. 10.1006/bbrc.1997.8019, 9464267.
20. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002, 31:141-149. 10.1038/ng892, 11992124.
21. Riou GF, Bourhis J, Le MG. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer. Anticancer Res 1990, 10:1225-1231.
22. Lee J, Yoon YS, Chung JH. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines. Gynecol Oncol 2008, 109:270-274. 10.1016/j.ygyno.2008.01.034, 18377964.
23. Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J, Chae M, Zhang W, Lee JH. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 2009, 124:287-297. 10.1002/ijc.23913, 19003969.
24. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?. Nat Rev Cancer 2006, 6:107-116. 10.1038/nrc1799, 16491070.
25. Ku JL, Kim WH, Park HS, Kang SB, Park JG. Establishment and characterization of 12 uterine cervical-carcinoma cell lines: common sequence variation in the E7 gene of HPV-16-positive cell lines. Int J Cancer 1997, 72:313-320. 10.1002/(SICI)1097-0215(19970717)72:2<313::AID-IJC19>3.0.CO;2-G, 9219839.